The Canadian Press - ONLINE EDITION

Swiss drug maker Roche enjoys strong profit, expects continued growth in 2014

  • Print

GENEVA - Swiss drug maker Roche saw its full-year profits boosted by strong demand for its cancer medicines and diagnostic tests used by clinical laboratories, the company reported Thursday.

Roche, the world's biggest manufacturer of cancer drugs, said it had net income of 11.2 billion Swiss francs ($12.4 billion) in 2013, an 18 per cent rise against 9.5 billion francs the year before.

The news sent shares of Roche up 4.3 per cent to close at 249.30 francs on the Zurich exchange Thursday.

"2013 was a very good year for Roche," CEO Severin Schwan said. "We exceeded our financial targets with strong demand for our existing products and positive uptake of recently launched medicines and diagnostics."

The company, based in Basel, Switzerland, said earnings are expected to continue to rise in 2014, with strong sales of a breast cancer medicine, Perjeta, and new products such as leukemia drug Gazyva and another breast cancer medicine, Kadcyla. The company has been investing in a lot of new drugs to replace its aging blockbusters, the drugs whose annual sales top $1 billion.

Schwan said the launch of Perjeta and Kadcyla added a new generation of treatments for women with a particularly aggressive type of breast cancer, and another highlight was Gazyva for chronic lymphocytic leukemia.

The company said it expects low to mid-single digit growth in sales and a further increase in its dividend this year.

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes

    No

  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Dustin Byfuglien reflects on season

View more like this

Photo Store Gallery

  • JOE BRYKSA/WINNIPEG FREE PRESS Local-(Standup photo)- A wood duck swims through the water with fall refections in Kildonan Park Thursday afternoon.
  • A goose heads for shade in the sunshine Friday afternoon at Woodsworth Park in Winnipeg - Day 26– June 22, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)

View More Gallery Photos

Poll

Do you think Manitoba needs stronger regulations for temporary workers?

View Results

View Related Story

Ads by Google